Notice: file_put_contents(): Write of 8581 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50
Readhub | Telegram Webview: readhub_cn/247321 -
Telegram Group & Telegram Channel
京东互联网医院上线“减重门诊” 专业诊疗方案助力个性化体重管理

京东互联网医院近日推出“减重门诊”,响应国家卫生健康委员会推进“体重管理年”3年行动,提供多学科专业力量的个性化减重服务。该门诊利用AI技术和中医辩证诊断方法,评估易胖体质类型,制定个性化减重方案,并提供科学的营养支持和运动方案。此外,京东到家快检上线“司美伴侣用药六联检”项目,为用户提供便捷的检测服务,辅助医生判断用药适应性并监测相关指标。京东互联网医院将继续创新互联网医疗服务模式,助力提升全民健康水平。

媒体报道
京东互联网医院上线“减重门诊” 电商报
京东互联网医院上线“减重门诊” 可提供个性化专业诊疗方案 亿邦动力网
京东互联网医院上线“减重门诊” 专业诊疗方案助力个性化体重管理 金融界

事件追踪
2024-12-26 京东互联网医院推出视频门诊服务
2022-12-16 互联网医院在线开具新冠处方获松绑,全国多家医疗机构上线新冠门诊

#热门话题



tg-me.com/readhub_cn/247321
Create:
Last Update:

京东互联网医院上线“减重门诊” 专业诊疗方案助力个性化体重管理

京东互联网医院近日推出“减重门诊”,响应国家卫生健康委员会推进“体重管理年”3年行动,提供多学科专业力量的个性化减重服务。该门诊利用AI技术和中医辩证诊断方法,评估易胖体质类型,制定个性化减重方案,并提供科学的营养支持和运动方案。此外,京东到家快检上线“司美伴侣用药六联检”项目,为用户提供便捷的检测服务,辅助医生判断用药适应性并监测相关指标。京东互联网医院将继续创新互联网医疗服务模式,助力提升全民健康水平。

媒体报道
京东互联网医院上线“减重门诊” 电商报
京东互联网医院上线“减重门诊” 可提供个性化专业诊疗方案 亿邦动力网
京东互联网医院上线“减重门诊” 专业诊疗方案助力个性化体重管理 金融界

事件追踪
2024-12-26 京东互联网医院推出视频门诊服务
2022-12-16 互联网医院在线开具新冠处方获松绑,全国多家医疗机构上线新冠门诊

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/247321

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

That growth environment will include rising inflation and interest rates. Those upward shifts naturally accompany healthy growth periods as the demand for resources, products and services rise. Importantly, the Federal Reserve has laid out the rationale for not interfering with that natural growth transition.It's not exactly a fad, but there is a widespread willingness to pay up for a growth story. Classic fundamental analysis takes a back seat. Even negative earnings are ignored. In fact, positive earnings seem to be a limiting measure, producing the question, "Is that all you've got?" The preference is a vision of untold riches when the exciting story plays out as expected.

At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?

Readhub from ca


Telegram Readhub
FROM USA